Stay tuned for an exciting Covid-19 study and a newly identified thrombosis biomarker to be presented at the American Heart Association meeting on Nov 13th by our founder, Dr. David Farrell, Professor at OHSU Medical School, Founder and Chief Scientific Officer at Gamma Diagnostics, Inc.
Search
Recent Posts
See AllGamma Diagnostics Inc. (GDx) and Oregon Health & Science University (OHSU) have signed a licensing agreement that seeks to further develop and commercially promote the use of Gamma Prime Fibrinoge
50
Dr. David Farrell, clinical professor of surgery at OHSU and founder and Chief Scientific Officer at Gamma Diagnostics Inc., shares his poster and abstract at the American Heart Association meeting.
1170
We are happy to announce Gamma Diagnostics joined Expert DOJO's September 2021 #healthcare accelerator program. With their healthcare industry expertise, they are giving 110% to transform the healthc
36